Molecular imaging of DNA synthesis using a new PET tracer: clinical study of diagnosis and therapeutic assessment for esophageal cancer
Phase 2
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-UMIN000018058
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Unable to have signed informed consent. 2) Patient with severe comorbid disease including liver dysfunction, renal dysfunction or metabolic damage. 3) Uncontrollable diabetics. 4) Those who are determined as not appropriate for the study by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To explore how 4DST-PET can contribute to initial diagnosis, treatment planning and therapeutic assessment of esophageal cancer.
- Secondary Outcome Measures
Name Time Method